abstract |
Disclosed are compounds of formula (I), methods for using these compounds to inhibit HPK1 activity, and pharmaceutical compositions containing such compounds. Such compounds can be used to treat, prevent, or ameliorate diseases or disorders associated with HPK1 activity, such as cancer. |